Cancer Research4d
Pembrolizumab Shot on Par with IV
Merck announced today that pembrolizumab (Keytruda) injected subcutaneously is not inferior to intravenous (IV) dosing, currently the drug’s only approved route of administration. In the phase III ...
Cancer Research6d
Abstract B006: Role of the BAF complex in pancreatic cancer-associated fibroblast function
Search for other works by this author on: ...
Cancer Research6d
Abstract A015: Aging limits stemness and tumor development in the lung by reprogramming iron homeostasis
Aging is the most important and well-recognized risk factor for cancer. Aging leads to systemic decline of physical fitness, significantly changing the macroenvironment from the early tumor initiation ...
Cancer Research6d
Abstract PR015: Sepsis-induced inflammation alters natural killer cell-mediated surveillance of liver metastasis
Search for other works by this author on: ...
Cancer Research6d
Abstract C033: Identifying and targeting prostate cancer therapy resistance mechanisms driven by the tumor microenvironment
1Fred Hutchinson Cancer Center, Seattle, WA.
Cancer Research6d
Abstract IA007: Respiratory viral infection promotes the awakening and outgrowth of dormant metastatic breast cancer cells in lungs
Breast cancer is the second most common cancer globally. Most deaths from breast cancer are due to metastatic disease which often follows long periods of clinical dormancy. Understanding the ...
Cancer Research6d
Abstract IA014: Unraveling pancreatic tumor defenses: inside the stromal orchestra with the HOST-factor
Dive into how members of the Cukierman lab and their collaborators explore desmoplasia, the dense “shield” around tumors. Discover their groundbreaking 3D model that reveals the intricate “symphony” ...